v3.10.0.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures Abstract  
Schedule of recurring fair value measurements
Fair Value Measurements At Reporting Date
Quoted pricesSignificantSignificantMeasured at
Balance atin activeother observableunobservable Net Asset Value
December 31,marketsinputsinputsas a Practical
Description 2018Level 1Level 2Level 3Expedient (2)
(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)$30,928$23,476$-$-$7,452
Quoted pricesSignificantSignificantMeasured at
Balance atin activeother observableunobservable Net Asset Value
December 31,marketsinputsinputsas a Practical
Description 2017Level 1Level 2Level 3Expedient (2)
(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)$40,995$23,751$-$-$17,244
Schedule Of Carrying Value Of Financial Instruments
December 31,December 31,
20182017
CarryingFairCarryingFair
ValueValueValueValue
(amounts in thousands)
Term B Loans (1)$1,291,700$1,243,261$1,330,000$1,336,650
Revolver (2)$180,000$180,000$143,000$143,000
Senior Notes (3)$400,000$378,000$400,000$422,876
Other debt (4)$912$70
Letters of credit (4)$5,862$1,856
Schedule of Cost Method Investments Table Text Block
Investments Valued Under the
Measurement Alternative
December 31,
20182017
(amounts in thousands)
Investment balance before cumulative
impairment as of January 1,$9,955$255
Accumulated impairment as of January 1,--
Investment beginning balance after cumulative
impairment as of January 1,9,955255
Acquisition of interest in a privately held company1,2509,700
Ending period balance$11,205$9,955